Home Clinical Topics FDA expands indication for two transcatheter heart valves

FDA expands indication for two transcatheter heart valves

On Aug. 18, the Food and Drug Administration (FDA) approved an expanded indication for the Sapien XT and Sapien 3 transcatheter heart valves for patients with aortic valve stenosis who are at intermediate risk for death or complications associated with open-heart surgery. Read more

LEAVE A REPLY

Please enter your comment!
Please enter your name here